[1]张 宁,董一平,袁 强,等.中医药通过作用破骨细胞调控治疗绝经后骨质疏松研究进展[J].陕西中医杂志,2024,(1):136-138,142.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.032]
　ZHANG Ning,DONG Yiping,YUAN Qiang,et al.Advances in the treatment of postmenopausal osteoporosis by Chinese medicine using osteoclasts[J].,2024,(1):136-138,142.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.032]
点击复制

中医药通过作用破骨细胞调控治疗绝经后骨质疏松研究进展
分享到：

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
136-138,142
栏目:
综 述
出版日期:
2024-01-05

文章信息/Info

Title:
Advances in the treatment of postmenopausal osteoporosis by Chinese medicine using osteoclasts
作者:
张 宁 1; 2; 董一平2; 3; 袁 强2; 3; 林继红2; 李无阴2; 张 颖2
(1.湖南中医药大学,湖南 长沙 410208; 2.河南省洛阳正骨医院 河南省骨科医院,河南 洛阳 471002; 3.河南中医药大学,河南 郑州 450046)
Author(s):
ZHANG Ning; DONG Yiping; YUAN Qiang; LIN Jihong; LI Wuyin; ZHANG Ying
(Hunan University of Chinese Medicine,Changsha 410208,China)
关键词:
骨质疏松;  绝经;  破骨细胞;  骨折;  骨吸收
Keywords:
Osteoporosis;  Postmenopausal;  Osteoclasts;  Bone formation;  Bone resorption
分类号:
R 271.116
DOI:
DOI:10.3969/j.issn.1000-7369.2024.01.032
文献标志码:
A
摘要:
绝经后骨质疏松(PMOP)是绝经后女性由于破骨细胞的骨吸收和成骨细胞的骨形成失衡而引起的常见骨性疾病,其临床表现主要以活动受限,浑身疼痛甚至骨脆性增加易骨折为主。临床上我们常选用西医治疗为首选方法,但随着大家对中医的了解加深,中医在治疗绝经后骨质疏松上的优势逐渐被发现。现重点对近几年研究的中药及其复方作用破骨细胞来防治绝经后骨质疏松的机制加以归纳总结,为临床防治绝经后骨质疏松症提供新思路与方法,并为后续中医药在绝经后骨质疏松上有更好的运用提出展望。
Abstract:
Postmenopausal osteoporosis(POMP)is a common bone disease in postmenopausal women caused by imbalance in bone resorption of osteoclasts and bone formation of osteoclasts.In clinic,we often choose western medicine as the preferred method,but with the deepening of our understanding of Chinese medicine,the advantages of Chinese medicine in the treatment of postmenopausal osteoporosis have been gradually discovered.This article will focus on the recent studies of traditional chinese medicine and its combination of osteoclasts to prevent and treat postmenopausal osteoporosis,provide new ideas and methods for clinical prevention and treatment of postmenopausal osteoporosis,and put forward a future for the better use of chinese medicine in postmenopausal osteoporosis.

参考文献/References:

[1] 苏奇,张文贤,王斌,等.中医药治疗绝经后骨质疏松症的实验研究进展[J].中医临床研究,2021,13(10):146-148.
[2] 岳建彪,苟静,魏翾娣,等.中医综合疗法联合运动干预治疗老年绝经后骨质疏松症临床研究[J].陕西中医,2022,43(10):1380-1383.
[3] ARMAS L A,RECKER R R.Pathophysiology of osteoporosis:New mechanistic insights[J].Endocrinol Metab Clin North Am,2012,41(3):475-486.
[4] 史晓林,吴连国,刘康.绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版)[J].中医正骨,2020,32(2):1-13.
[5] 邵佳乐,周建,李志忠,等.雌激素受体信号通路与骨质疏松症相关性的研究进展[J].中国生物制品学杂志,2020,33(8):956-960.
[6] 孙伟明,刘爽.雌激素影响绝经后骨质疏松分子机制研究进展[J].中国老年学杂志,2017,37(2):499-502.
[7] 周大标,吴冰心,阳越,等.基于肝脾肾探讨绝经后骨质疏松症治疗机制[J].陕西中医,2022,43(6):752-754,766.
[8] 于冬冬,李泽,李鑫,等.绝经后骨质疏松症中医辨证分型和治疗研究进展[J].辽宁中医药大学学报,2020,22(3):61-63.
[9] 卫荣,史红霞.绝经后骨质疏松症骨代谢标志物与中医证型的研究[J].新疆医科大学学报,2018,41(9):1178-1181.
[10] 陈易.绝经后骨质疏松症证素与性激素、骨密度、体重指数的相关性研究[D].济南:山东中医药大学,2017.
[11] 王山林,骆新波,黄煊,等.破骨细胞功能调控与骨质疏松症的关系研究[J].中国现代药物应用,2021,15(13):3.
[12] 王想福,孙凤歧,叶丙霖,等.破骨细胞与骨质疏松症的关系研究进展[J].中国骨质疏松杂志,2015,21(11):1420-1424.
[13] 张萌萌.雌激素与雌激素受体骨代谢调节作用[J].中国骨质疏松杂志,2019,25(5):704-708.
[14] 林子豪,王一宇.雌激素与骨改建[J].济宁医学院学报,2019,42(6):432-435,440.
[15] WEAVER C M,ALEXANDER D D,BOUSHEY C J,et al.Calcium plus vitamin D supplementation and risk of fractures:An updated meta-analysis from the National Osteoporosis Foundation[J].Osteoporos Int,2016,27(1):367-376.
[16] MUNOZ-TORRES M,ALONSO G,RAYA M P.Calcitonin therapy in osteoporosis[J].Treat Endocrinol,2004,3(2):117-132.
[17] YUAN F,PENG W,YANG C,et al.Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis:A meta-analysis[J].Int J Surg,2019,66:1-11.
[18] 刘小钰,宋敏,蒋林博,等.补骨脂活性成分对骨质疏松相关信号通路影响的研究概况[J].中国骨质疏松杂志,2017,23(6):831-836.
[19] 李啸群,徐凯航,纪方.补骨脂异黄酮抑制破骨细胞分化缓解小鼠去卵巢骨质疏松[J].中国组织工程研究,2021,25(2):186-190.
[20] 章文娟,谢保平,李伟娟,等.补骨脂素抑制破骨细胞形成及其机制的实验研究[J].第三军医大学学报,2017,39(7):641-645.
[21] 马运锋,韩小飞.丹参多酚酸酯调控SMAD2/FKBP1A/NF-κB轴对骨质疏松症大鼠破骨细胞分化和骨吸收的影响[J].吉林大学学报(医学版),2022,48(1):111-121.
[22] QIN H,ZHAO W,JIAO Y,et al.Aqueous extract of salvia miltiorrhiza Bunge-Radix puerariae herb pair attenuates osteoporosis in ovariectomized rats through suppressing osteoclast differentiation[J].Front Pharmacol,2020,11:581049.
[23] WANG X,ZHANG M,ZHANG D,et al.Structural elucidation and anti-osteoporosis activities of polysaccharides obtained from curculigo orchioides[J].Carbohydr Polym,2019,203:292-301.
[24] 刘梦琴,张奇,朱露琳,等.仙茅苔黑酚类酚苷对去卵巢大鼠骨代谢和破骨细胞形成分化的影响[J].中国药学杂志,2021,56(2):99-107.
[25] LIU M,LIU S,ZHANG Q,et al.Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells[J].J Ethnopharmacol,2021,275:114-129.
[26] LI J,JI L,SUN L,et al.Analysis of herba asari polysaccharides and their immunological activity[J].Carbohydr Polym,2012,87(1):551-556.
[27] 周丽群.铁皮石斛有效成分及药理作用的研究[J].中阿科技论坛:中英文,2020,4(8):3.
[28] 彭聪聪.铁皮石斛对去卵巢骨质疏松大鼠OPG/RANKL/RANK轴的初步研究[D].南宁:广西中医药大学,2020.
[29] WANG Q,ZI C T,WANG J,et al.Dendrobium officinale orchid extract prevents ovariectomy-induced osteoporosis in vivo and inhibits rankl-induced osteoclast differentiation in vitro[J].Front Pharmacol,2017,8:966.
[30] XUE L,JIAO L,WANG Y,et al.Effects and interaction of icariin,curculigoside,and berberine in er-xian decoction,a traditional chinese medicinal formula,on osteoclastic bone resorption[J].Evid Based Complement Alternat Med,2012,2012:490843.
[31] 汪青.二仙汤治疗肾阳虚型绝经后骨质疏松症的临床疗效评价及基于网络药理学的机制研究[D].南京:南京中医药大学,2021.
[32] 汪青,黄昊强,陈勇,等.二仙汤在绝经后骨质疏松症肾阳虚证治疗中的应用价值及作用机制研究[J].中医正骨,2022,34(3):8-14.
[33] 田涛,傅强,朱健奎,等.二至丸治疗斑马鱼骨质疏松模型效益观察及破骨细胞自噬机制[J].南京中医药大学学报,2020,36(3):352-357.
[34] 韩龙,谭登,万仕炜,等.二至丸对绝经后骨质疏松模型大鼠脂肪组织糖代谢影响[J].南京中医药大学学报,2022,38(5):419-423,438.
[35] 姜宜妮,梁健,闵建新,等.二至丸对绝经后骨质疏松鼠的作用观察及可能机制研究[J].世界中医药,2020,15(21):3255-3259,3265.
[36] 王洋,郭万首,程立明,等.六味地黄丸治疗绝经后骨质疏松症疗效的系统评价和Meta分析[J].中国骨质疏松杂志,2020,26(5):663-670,688.
[37] 王雷,李盛华.六味地黄丸治疗绝经后骨质疏松症作用机制[J].中国骨质疏松杂志,2021,27(7):1042-1049.
[38] 李微,朱汉民,王鑫,等.左归丸干预卵巢摘除骨质疏松模型小鼠骨形态发生蛋白2信号通路的变化[J].中国组织工程研究,2022,26(8):1173-1179.
[39] 刘立萍,李然,李雪峰,等.补肾填精方对快速老化模型小鼠活化的T细胞转录核因子蛋白表达的影响[J].时珍国医国药,2017,28(9):2085-2087.

相似文献/References:

[1]贾 辉.利塞膦酸钠联合中药对老年女性髋骨骨折的影响研究*[J].陕西中医杂志,2019,(2):226.
[2]李鸿,徐无忌△.加味身痛逐瘀汤治疗骨质疏松椎体压缩性骨折经皮穿刺椎体成形术后残余痛临床研究*[J].陕西中医杂志,2019,(11):1545.
　LI Hong,XU Wuji..Clinical observation on residual pain after PVP in the treatment of osteoporotic vertebral compression fracture with Jiawei Shentong Zhuyu decoction[J].,2019,(1):1545.
[3]杨庆万,安 阳△,项飞燕,等.引火汤对类风湿关节炎患者骨代谢的影响*[J].陕西中医杂志,2020,(1):73.
　YANG Qingwan,AN Yang,XIANG Feiyan,et al.Effect of Yinhuo decoction on bone metabolism in patients with rheumatoid arthritis[J].,2020,(1):73.
[4]刘志刚,秦 琳,张挥武△.温针灸联合经皮椎体后凸成形术治疗骨质疏松性椎体压缩性骨折疗效及对患者骨密度和血钙的影响*[J].陕西中医杂志,2020,(6):823.[doi:DOI:10.3969/j.issn.10007369.2020.06.035]
　LIU Zhigang,QIN Lin,ZHANG Huiwu..Efficacy of warm acupuncture combined with percutaneous kyphoplasty in treating of osteoporotic vertebral compression fracture and the effect on BMD and serum calcium level[J].,2020,(1):823.[doi:DOI:10.3969/j.issn.10007369.2020.06.035]
[5]申杨勇,陈京峰,崇 辉.四神煎加减联合青鹏软膏对骨质疏松性胸腰椎压缩性骨折患者术后疼痛及骨折愈合的影响[J].陕西中医杂志,2020,(12):1719.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.010]
[6]张雅梦,高彦利,胡亚男,等.定经汤加减在经断前后诸证中的应用研究进展[J].陕西中医杂志,2023,(5):678.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.034]
　ZHANG Yameng,GAO Yanli,HU Ya'nan,et al.Research progress on the application of Dingjing decoction in various syndromes before and after menstrual breakage[J].,2023,(1):678.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.034]
[7]张民珍,罗 文,杨黎艳,等.巴戟天多糖对大鼠骨质疏松的作用机制研究[J].陕西中医杂志,2024,(3):302.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.003]
　ZHANG Minzhen,LUO Wen,YANG Liyan,et al.Study on mechanism of Morinda polysaccharide on osteoporosis in rats[J].,2024,(1):302.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.003]
[8]姜凤依,施 丹,季思勤,等.补肾健脾通络方结合五行健骨操对老年骨质疏松脾肾两虚证患者骨密度、骨代谢及炎症水平的影响[J].陕西中医杂志,2024,(4):485.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.011]
　JIANG Fengyi,SHI Dan,JI Siqin,et al.Effects of Bushen Jianpi Tongluo formula combined with five elements bone-building exercises on bone mineral density,bone metabolism and inflammation in elderly patients with spleen-kidney deficiency syndrome of osteoporosis[J].,2024,(1):485.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.011]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81774348,81874477); 河南省科技攻关项目(202102310152); 河南省卫生健康中青年学科带头人资助项目(HNSWJW-2020028); 河南省中医药科学研究专项课题(20-21ZY2247)
更新日期/Last Update: 2024-01-09